TAKE16.78

TAKE Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersVIMTALABSSUVENMcap ₹248 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations65.60.054.284.6
Other Income1.610.26.78.0
Total Income67.210.260.992.5
Expenses
+ Cost of Materials Consumed24.40.00.00.0
+ Purchases of Stock-in-Trade0.00.054.284.5
+ Employee Benefit Expense15.01.10.40.4
+ Finance Costs5.42.00.30.2
+ Depreciation & Amortisation7.90.00.00.0
+ Other Expenses39.76.41.51.5
Total Expenses92.49.556.586.5
EBITDA-13.5-7.5-1.9-1.7
EBIT-21.3-7.5-1.9-1.7
Profit
PBT before Exceptional Items-25.20.74.46.1
+ Exceptional Items-93.20.00.00.0
Pretax Income-118.40.74.46.1
+ Current Tax0.70.00.00.2
+ Deferred Tax0.50.00.20.0
Tax Expense1.20.00.20.2
Net Income-119.637.510.812.8
+ Net Income — Continuing Ops-119.60.74.35.9
+ Net Income — Discontinued Ops0.036.76.66.9
+ Other Comprehensive Income-0.0-0.00.00.1
Total Comprehensive Income-119.637.410.912.9
Net Income to Common-119.637.5
Per Share
Basic EPS-8.182.560.740.86
Diluted EPS-8.182.560.740.86
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.036.76.66.9
+ Tax — Discontinued Operations0.0-0.00.00.0
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.00.0
+ Items NOT to be Reclassified to P&L-0.00.1
+ Tax on Items NOT to be Reclassified — alt tag-0.0
+ Items to be Reclassified to P&L0.0-0.1
+ Tax on Items to be Reclassified0.0-0.0
Comprehensive Income — Owners of Parent-0.0-0.1
Comprehensive Income — Non-controlling Interests-119.60.0
Per Share — as-filed variants
Basic EPS — Continuing Operations-8.180.050.290.39
Diluted EPS — Continuing Operations-8.180.050.290.39
Basic EPS — Discontinued Operations0.002.510.450.47
Diluted EPS — Discontinued Operations0.002.510.450.47
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit41.20.0-0.00.1
Gross Margin %62.75-0.030.11
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)-25.20.74.46.1
− Exceptional Items (reconciliation)-93.20.00.00.0
Net Income Adj (tax-effected)-26.437.510.812.8
EPS Adj-1.812.560.740.86
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.00
Paid Up Equity Capital14.614.614.814.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.